Beauty Health (NASDAQ:SKIN) Reaches New 1-Year Low – Should You Sell?

The Beauty Health Company (NASDAQ:SKIN) hit a new 52-week low during mid-day trading on Wednesday. The company traded as low as $10.01 and last traded at $11.1470, with a volume of 10,324 shares. The stock had previously closed at $10.8120.

Analyst Upgrades and Downgrades

Several analysts have recently commented on SKIN shares. Weiss Ratings cut Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, July 23rd. TD Cowen lowered their price objective on Beauty Health from $20.00 to $18.00 and set a “hold” rating for the company in a research report on Wednesday, August 12th. Zacks Research lowered Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th. Stifel Nicolaus set a $10.00 target price on Beauty Health in a research note on Thursday. Finally, Citigroup restated a “hold” rating on shares of Beauty Health in a research report on Thursday. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $24.00.

Beauty Health Stock Performance

The company has a debt-to-equity ratio of 4.36, a quick ratio of 1.48 and a current ratio of 1.76. The company has a market capitalization of $82.03 million, a price-to-earnings ratio of -2.86 and a beta of 1.05. The firm has a 50-day simple moving average of $12.99 and a two-hundred day simple moving average of $14.56.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.40) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.50) by $0.10. Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. The business had revenue of $72.11 million for the quarter, compared to analysts’ expectations of $74.45 million. On average, sell-side analysts anticipate that The Beauty Health Company will post -3.20 EPS for the current fiscal year.

Institutional Investors Weigh In On Beauty Health

Hedge funds have recently added to or reduced their stakes in the business. Diversified Trust Co purchased a new position in Beauty Health in the 1st quarter valued at approximately $25,000. Bank of America Corp DE increased its position in shares of Beauty Health by 19.2% during the first quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock worth $95,000 after acquiring an additional 17,088 shares during the period. Renaissance Technologies LLC increased its position in shares of Beauty Health by 29.6% during the first quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock worth $253,000 after acquiring an additional 64,900 shares during the period. Finally, Capricorn Fund Managers Ltd purchased a new stake in shares of Beauty Health during the first quarter worth $17,270,000. 93.26% of the stock is currently owned by institutional investors and hedge funds.

Beauty Health Company Profile

BeautyHealth is a global health and beauty company focused on creating technology-enabled products and experiences for skin health. Its primary brand is Hydrafacial, which offers non-invasive skin treatments that combine cleansing, exfoliation, extraction and hydration with professional-grade devices, serums and treatment boosters.

The company also provides products and systems designed for complementary aesthetic and wellness applications, including Syndeo, a connected Hydrafacial delivery system; Keravive, a scalp-health treatment; and SkinStylus, a microneedling platform.